rabeprazole has been researched along with Pneumonia, Aspiration in 3 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Pneumonia, Aspiration: A type of lung inflammation resulting from the aspiration of food, liquid, or gastric contents into the upper RESPIRATORY TRACT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The proportion of patients at risk of acid aspiration syndrome according to the traditional criteria (pH < 2." | 2.69 | A comparison of rabeprazole, lansoprazole, and ranitidine for improving preoperative gastric fluid property in adults undergoing elective surgery. ( Maekawa, N; Mikawa, K; Nishina, K; Obara, H; Shiga, M; Takao, Y, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirota, K | 2 |
| Imai, A | 1 |
| Kudo, M | 2 |
| Hashimoto, H | 2 |
| Kushikata, T | 2 |
| Nishina, K | 1 |
| Mikawa, K | 1 |
| Takao, Y | 1 |
| Shiga, M | 1 |
| Maekawa, N | 1 |
| Obara, H | 1 |
2 trials available for rabeprazole and Pneumonia, Aspiration
| Article | Year |
|---|---|
Efficacy of a single 24-hour pre-anesthetic dose of proton pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Aged; Drug Administration Schedule; F | 2009 |
A comparison of rabeprazole, lansoprazole, and ranitidine for improving preoperative gastric fluid property in adults undergoing elective surgery.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Double-Blin | 2000 |
1 other study available for rabeprazole and Pneumonia, Aspiration
| Article | Year |
|---|---|
The efficacy of preanesthetic proton pump inhibitor treatment for patients on long-term H2 antagonist therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Drug Tolera | 2005 |